Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 5,722

Document Document Title
WO/2023/145758A1
Provided is a method for producing a fluorine-containing phthalic acid derivative, whereby a fluorine-containing phthalic acid derivative can be obtained using a simple process. This method for producing a fluorine-containing phthalic ac...  
WO/2023/139091A1
Identification of small organic molecules capable of stimulating aerobic glycolysis and cone survival would lead to the conception of new therapies of the retinal degenerative diseases.Now the inventors identified Geralexin, an acetogeni...  
WO/2023/137453A1
The present disclosure relates to compounds Formula (I): methods for making the compounds and methods for their use.  
WO/2023/135107A1
The present invention relates to a compound of general formula (I) inhibiting the transforming growth factor-β (TGF-β) type I receptor (ALK5), methods of preparing such compounds, pharmaceutical compositions containing them and therape...  
WO/2023/137446A1
The present disclosure relates to prodrugs of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), methods for making the prodrugs and the methods for their use in treating brain and neurological disorders.  
WO/2023/131868A1
The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of GLUT9 for the treatment or prevention of hyperuricemia and gout.  
WO/2023/132490A1
The present specification relates to a compound of chemical formula 1 and an organic light-emitting device comprising same.  
WO/2023/132489A1
The present specification relates to a compound of chemical formula 1 and an organic light-emitting device comprising same.  
WO/2023/125716A1
Provided in the present invention are a class of quinoline compounds and a preparation method therefor, a pharmaceutical composition and the use thereof. Specifically, provided in the present invention are a compound as shown in formula ...  
WO/2023/127809A1
In the production of agricultural and horticultural crops, etc., damages caused by pest insects, etc. are still significant, and, therefore, the development of novel pest control agents has been required due to factors such as the emerge...  
WO/2023/127805A1
In the production of crops in agriculture, horticulture, and the like, the occurrence of damage by pests and the like has been still a major issue, and therefore the development of new agricultural/horticultural pesticides has been deman...  
WO/2023/121992A1
The invention provides new heterocyclic compounds having the general formula (I'), or a solvate or a pharmaceutically acceptable salt thereof: wherein R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein, compositions including the co...  
WO/2023/118715A1
The present invention relates to a process for synthesising 5-((2-methyl-1H-imidazol-1-yl)methyl)furan-2-carbaldehyde from a mixture comprising a carbohydrate, an alkali metal chloride or alkaline earth metal chloride, hydrochloric acid,...  
WO/2023/108363A1
Provided are compounds of Formula (I) and the preparation methods of these compounds, and their use as P2Y12 receptor antagonists in the treatment and/or prevention of thrombosis or related disorders.  
WO/2023/108036A1
In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, the disclosure, in one aspect, relates to sulfur- and selenium-containing compounds that act as agonists and/or antagonists of cannabi...  
WO/2023/104201A1
An aryl C-glucoside derivative, a preparation method therefor and the use thereof. Specifically provided are an aryl C-glucoside derivative as shown in formula I, a tautomer thereof, a stereoisomer thereof, a prodrug thereof, or a pharma...  
WO/2023/103850A1
Provided are a small molecule STING agonist, a preparation method therefor, and an application. Specifically, the present invention provides the compound represented by structural formula I, the compound having STING agonist activity. Th...  
WO/2023/097697A1
Provided is a method for synthesizing (1R)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)oxazolidin-2-on e, the route of the method being as follows: [Route 1], wherein X is Br, Cl or I, and R1 and R2 are protective groups that can be removed....  
WO/2023/096209A1
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second electrode; and an...  
WO/2023/092195A1
Analogues of 3,4-methylenedioxymethamphetamine (MDMA), processes for their preparation, medicaments and medical methods of treatment comprising said MDMA analogues, and medical uses of said MDMA analogues. The MDMA analogues are capable ...  
WO/2023/094734A1
The present invention relates to novel ligands for vesicular glutamate transporters, VGLUTs, and the use thereof in diagnostic methods and therapeutic applications. The invention also relates to the use of fluorescent properties of novel...  
WO/2023/090822A1
The present invention provides a cannabichromenic acid derivative, a preparation method therefor, and a composition comprising same for improving cognitive function. A novel cannabichromenic acid derivative of the present invention has b...  
WO/2023/092107A1
The present disclosure provides a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof useful for treating a cancer.  
WO/2023/091674A1
Described herein are compounds which are inhibitors of oncogenic and wild-type SHP2 and methods of treatment using SHP2 inhibitors.  
WO/2023/092088A1
The present disclosure provides a compound represented by structural formula (I): (I), or a pharmaceutically acceptable salt thereof useful for treating a cancer.  
WO/2023/081967A1
Provided herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising said compounds. Also provided are uses of the compounds for sensitising bacterial cells expressing EptA...  
WO/2023/076494A1
Methods and agricultural formulations for the cultivation of plants such as broad acre crops, fruits and vegetables, perennial tree crops, and ornamentals are described. The methods include contacting the plant with a furanone compound a...  
WO/2023/063701A1
The present invention provides a novel compound for a capping layer, and an organic light-emitting device comprising same.  
WO/2023/054626A1
Provided is a cyclopropanamide derivative. A compound represented by formula (1) [wherein: n represents an integer of 0, 1, 2 or 3; ring A represents (1) 4-pyridyl which may be substituted with 1 to 4 substituents, or (2) phenyl which is...  
WO/2023/052593A1
The invention concerns compounds having antiviral activity, in particular having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising th...  
WO/2023/043040A1
The present invention provides a novel compound for a light-emitting device, and an organic light-emitting device comprising same.  
WO/2023/038495A1
The present specification relates to a compound of chemical formula 1, a coating composition comprising the compound, an organic light-emitting device using same, and a manufacturing method therefor.  
WO/2023/033355A1
The present invention provides: a compound represented by formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode; and an...  
WO/2023/034411A1
Compounds, compositions, and methods for controlling the level of a target protein in a cell are described. Compounds of the disclosure include those having according to the formula PTM-L-LTM, wherein PTM is a targeting moiety that binds...  
WO/2023/027336A1
The present specification relates to: a heterocyclic compound represented by chemical formula 1; and an organic light-emitting device comprising same.  
WO/2023/025276A1
Disclosed in the present invention is a compound having a structure shown in general formula I, or a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a solvate thereof. Further disclosed in the present invention are a...  
WO/2023/027479A1
The present application provides: a heterocyclic compound which can significantly improve the service life, efficiency, electrochemical stability, and thermal stability of an organic light-emitting device; and an organic light-emitting d...  
WO/2023/020479A1
The present invention relates to a compound having a PARP7 inhibitory effect as shown in formula (I), and a pharmaceutically acceptable salt, a stereoisomer, a solvate, or a prodrug thereof, and use thereof and a preparation method there...  
WO/2023/020457A1
Provided herein are novel compounds, for example, compounds having a Formula (I), or a pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same. Also provided herein are methods of preparing the compou...  
WO/2023/021081A1
The present invention relates to a method for producing at least one vinyl ether compound having at least one cyclic structure using at least one Iridium catalyst, at least one base and at least one solvent selected from ester and/or eth...  
WO/2023/022417A1
Provided is a cyano group-substituted heteroaryl amine derivative which effectively absorbs high-energy external light source in the UV region to minimize damage to organic materials inside an organic electroluminescent device, thus cont...  
WO/2023/017699A1
The present invention addresses the problem of providing: a 3-substituted uracil compound that has excellent germicidal/antimicrobial activity and excellent safety, while being industrially beneficially synthesized; and an agricultural/h...  
WO/2023/018052A1
Provided is a tertiary amine derivative, which effectively absorbs a high-energy external light source in a UV region so as to minimize damage to organic materials in an organic electroluminescent device, and thus contributes to a substa...  
WO/2023/018781A1
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes...  
WO/2023/010762A1
The present invention provides a preparation method for high-purity, small-particle-size pranlukast, comprising the steps: step 1, mixing a water-insoluble organic solvent with dimethylformamide, then adding crude pranlukast, and then he...  
WO/2023/011539A1
Provided are a polycyclic derivative regulator, a preparation method therefor, and an application thereof. In particular, provided are a compound represented by general formula (I'), a preparation method therefor, a pharmaceutical compos...  
WO/2023/008577A1
The present invention addresses the problem of providing a Ras/Raf binding inhibitor compound that has the effect of inhibiting Ras/Raf signaling in drug-resistant cancer cells and in a wide range of Ras mutant cancers. A Ras/Raf binding...  
WO/2023/003234A1
The present invention provides: a novel compound capable of improving the luminous efficiency, stability and lifespan of an element; an organic electric element using same; and an electronic device thereof.  
WO/2023/003313A1
The present invention relates to: an organic compound which is used for an organic layer, such as a hole transport layer or an electron blocking layer, in an organic light-emitting device; and an organic light-emitting device comprising ...  
WO/2023/287740A1
Compounds and compositions useful in methods of treating, ameliorating, or inhibiting the development of an autoimmune disease by modulating the T cell response to antigenic peptide or fragments of antigenic peptides presented by the maj...  

Matches 101 - 150 out of 5,722